TATVA CHINTAN PHARMA CHEM
|
TATVA CHINTAN PHARMA CHEM Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 17.98 | 2.44 | 12.98 | 20.52 | 43.25 |
| CEPS(Rs) | 33.73 | 14.27 | 23.92 | 24.83 | 46.95 |
| DPS(Rs) | 2.00 | 1.00 | 2.00 | 2.00 | 2.00 |
| Book NAV/Share(Rs) | 334.20 | 315.84 | 315.10 | 232.25 | 213.44 |
| Tax Rate(%) | 26.23 | 24.62 | 30.33 | -1.58 | 7.92 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 18.45 | 8.99 | 17.33 | 14.34 | 25.01 |
| EBIT Margin(%) | 11.88 | 2.37 | 12.75 | 12.60 | 25.20 |
| Pre Tax Margin(%) | 11.26 | 1.98 | 11.04 | 10.57 | 24.00 |
| PAT Margin (%) | 8.30 | 1.49 | 7.69 | 10.73 | 22.10 |
| Cash Profit Margin (%) | 15.58 | 8.71 | 14.18 | 12.99 | 23.98 |
| Performance Ratios | |||||
| ROA(%) | 4.63 | 0.70 | 3.91 | 6.53 | 19.68 |
| ROE(%) | 5.53 | 0.77 | 4.85 | 9.21 | 30.01 |
| ROCE(%) | 7.17 | 1.19 | 7.00 | 8.35 | 25.75 |
| Asset Turnover(x) | 0.56 | 0.47 | 0.51 | 0.61 | 0.89 |
| Sales/Fixed Asset(x) | 0.75 | 0.69 | 1.10 | 2.03 | 2.67 |
| Working Capital/Sales(x) | 3.71 | 2.26 | 1.81 | 5.76 | 1.64 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.33 | 1.44 | 0.91 | 0.49 | 0.37 |
| Receivable days | 75.16 | 75.93 | 71.34 | 60.72 | 61.98 |
| Inventory Days | 118.92 | 136.58 | 145.79 | 143.16 | 101.78 |
| Payable days | 73.91 | 71.30 | 80.91 | 61.91 | 86.25 |
| Valuation Parameters | |||||
| PER(x) | 58.46 | 278.00 | 83.19 | 81.23 | 53.35 |
| PCE(x) | 31.16 | 47.59 | 45.13 | 67.12 | 49.16 |
| Price/Book(x) | 3.14 | 2.15 | 3.43 | 7.18 | 10.81 |
| Yield(%) | 0.19 | 0.15 | 0.19 | 0.12 | 0.09 |
| EV/Net Sales(x) | 5.08 | 4.21 | 6.36 | 9.02 | 11.66 |
| EV/Core EBITDA(x) | 26.49 | 43.82 | 32.95 | 57.43 | 43.03 |
| EV/EBIT(x) | 42.73 | 177.15 | 49.73 | 71.57 | 46.25 |
| EV/CE(x) | 2.85 | 2.08 | 3.33 | 5.58 | 8.53 |
| M Cap / Sales | 4.86 | 4.15 | 6.42 | 8.72 | 11.80 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 32.18 | -2.74 | -7.11 | -2.31 | 44.38 |
| Core EBITDA Growth(%) | 163.93 | -51.58 | 14.10 | -43.40 | 63.52 |
| EBIT Growth(%) | 561.62 | -81.93 | -5.77 | -51.19 | 67.87 |
| PAT Growth(%) | 636.11 | -81.18 | -33.27 | -52.56 | 83.45 |
| EPS Growth(%) | 636.11 | -81.18 | -36.77 | -52.56 | 66.26 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.15 | 0.05 | 0.02 | 0.33 | 0.25 |
| Current Ratio(x) | 1.64 | 2.76 | 3.74 | 1.31 | 2.54 |
| Quick Ratio(x) | 0.72 | 1.37 | 1.82 | 0.63 | 1.55 |
| Interest Cover(x) | 19.16 | 6.01 | 7.47 | 6.21 | 20.90 |
| Total Debt/Mcap(x) | 0.05 | 0.02 | 0.01 | 0.05 | 0.02 |
Compare Financial Ratios of peers of TATVA CHINTAN PHARMA CHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TATVA CHINTAN PHARMA CHEM | ₹4,084.9 Cr | 14.1% | 7.7% | 67.4% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹180,844.0 Cr | -0.1% | -2.1% | 30% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹159,966.0 Cr | 3.5% | -5.2% | 2% | Stock Analytics | |
| SRF | ₹75,117.0 Cr | 3.7% | -1% | -13.1% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹49,324.9 Cr | -0.8% | -2.5% | 23.5% | Stock Analytics | |
| GODREJ INDUSTRIES | ₹37,031.7 Cr | 0.1% | -10% | -10.9% | Stock Analytics | |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TATVA CHINTAN PHARMA CHEM | 14.1% |
7.7% |
67.4% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses
